Sun Altbach, PIC Therapeutics’ Founding Chief Executive Officer, President and Board member has Announced She is Leaving the Company
May 7, 2020
Sun Altbach, PIC Therapeutics’ founding Chief Executive Officer, President and Board member has announced she is leaving the company to pursue other opportunities in the life sciences industry. To allow for a smooth transition,
Ms. Altbach will serve as an Advisor to the company over the coming months.
Dr. Alan Walts, Executive Chairman of the Board of Directors, and Dr. Richard Peters, PIC co-founder and Board member, will lead the search for a new CEO.
The Board thanks Ms. Altbach for her two-plus year tenure as founding CEO, during which she led the company as it transitioned out of academia, built a strong team and Scientific Advisory Board, and successfully closed two over-subscribed fundraising rounds, including PIC’s first equity raise in March 2020.
The PIC Board and Ms. Altbach are working together to ensure a seamless transition and the Board expects to provide further updates as to a new CEO in due course.